Shares of the pharmacy chain plummeted 25% after The Wall Street Journal reported the CEO’s plans and the company lowered its guidance for the full year.
Related Posts
PwC China Hit With Six-Month Ban Over Evergrande Crisis
Chinese regulators said the firm failed to maintain professional skepticism for its work related to the country’s recent real-estate bust.
David Boies Is in Delta’s Corner—and Faces an Old Foe
Fallout from last month’s software outage gives the famed lawyer a rematch with Microsoft.
Tesla Recalls More Than 1.8 Million Vehicles Due to Hood Issue
The National Highway Traffic Safety Administration said Tuesday that a software issue risks failing to warn a driver when the hood of the vehicle is […]